Press Room

WASHINGTON, D.C.

WASHINGTON, D.C.

WASHINGTON, D.C. – Cancer survivors, researchers and advocates, including Dr.

A new bill that would improve access to clinical trials was recently introduced  in the U.S. Senate. Sponsored by Senators Tim Scott (R-S.C.) and Mark Warner (D-Va.), the Clinical Trial Modernization Act (S. 4440) would help reduce cost and geographic barriers, making it easier for patients to take part in clinical trials. U.S. Representatives Raul Ruiz (D-Calif.) and August Pfluger (R-Texas) introduced the House version (H.R. 3521) of this legislation in May 2025.

As the administration releases its proposed budget for Fiscal Year 2027, the American Cancer Society Cancer Action Network (ACS CAN) is calling on Congress to maintain its longstanding bipartisan commitment to robust, increased investments in cancer research and prevention.  

MONTGOMERY, Ala. – In a show of unity among scientists across Alabama, more than 50 cancer researchers from multiple universities will gather for a symposium at the State House in Montgomery on Tuesday, March 31.

Earlier today, legislation was introduced in the New Jersey Assembly as a companion to Senate Bill 773, proposing to increase the state’s investment in the New Jersey Commission on Cancer Research (NJCCR). Assembly Bill 4579 would establish a dedicated, non-lapsing investment in the amount of $10 million, utilizing a greater proportion of the state tobacco tax revenue to do so. With bills now moving in both chambers, survivors and advocates with the American Cancer Society Cancer Action Network (ACS CAN) are encouraged by the growing momentum to expand support for cancer research and accelerate lifesaving innovations.

Following today’s health-Medicaid budget hearing, more than a dozen cancer survivors and ACS CAN advocates gathered at the New York State Capitol to call on lawmakers to preserve access to biomarker testing, a priority shared by over 100 organizations statewide. Advocates also expressed hope that the one‑house and final budgets will include meaningful investments in cancer prevention and early detection. 

This week, Congress officially passed its FY26 appropriations bill that delivers major wins in the fight against cancer and reinforces that cancer remains a national priority.

With the imminent release of Governor Wes Moore’s executive budget proposal, cancer survivors are increasingly anxious about what this budget will mean for three key line items. They are hopeful that the state restores funding for the tobacco control program and maintains its investments in the Breast and Cervical Cancer Diagnosis and Treatment Program (BCCDT) as well as ongoing research at the University of Maryland Medical System Stewart Greenebaum Cancer Center and the Johns Hopkins University Sidney Kimmel Cancer Center. Their message to the governor and General Assembly: cancer prevention and early detection and the research behind modern screening, treatment and prevention tools are critical in the fight against cancer.